The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIWG Regulatory News (IWG)

Share Price Information for IWG (IWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 183.10
Bid: 183.20
Ask: 183.70
Change: -0.40 (-0.22%)
Spread: 0.50 (0.273%)
Open: 183.30
High: 184.00
Low: 181.90
Prev. Close: 183.50
IWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - IWG plc

27 Jun 2018 15:25

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1 KEY INFORMATION
(a) Full name of discloser: MELQART ASSET MANAGEMENT (UK) LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: IWG plc
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken: 26 June 2018
For an opening position disclosure, state the latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? NO
If it is a cash offer or possible cash offer, state “N/A” If YES, specify which:
2 POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 1p ordinary
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: 11,374,000 1.25%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 11,374,000 1.25%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3 DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit GBp
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short position
1p ordinary CFD Increasing a long position 86,500 324.60
1p ordinary CFD Increasing a long position 31,867 324.62
1p ordinary CFD Increasing a long position 41,312 323.55
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4 OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 27 June 2018
Contact name: J. H. Austin
Telephone number: 020 3826 4492
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180627005085/en/

Copyright Business Wire 2018

Date   Source Headline
22nd Apr 20245:30 pmRNSAnnual General Meeting 2024
2nd Apr 20244:40 pmRNSTotal Voting Rights: Month End Disclosure
28th Mar 20244:40 pmRNSDirector/PDMR Transaction
20th Mar 20244:00 pmRNSDirector/PDMR Transaction
20th Mar 20244:00 pmRNSDirector/PDMR Transaction
20th Mar 20244:00 pmRNSDirector/PDMR Transaction
19th Mar 20247:00 amRNSAnnual Report and Accounts 2023
6th Mar 20244:00 pmRNSDirector/PDMR Transaction
6th Mar 20244:00 pmRNSDirector/PDMR Transaction
5th Mar 20247:00 amRNSIWG FY 2023 Preliminary Results
4th Mar 202410:38 amRNSTotal Voting Rights: Month End Disclosure
22nd Feb 20245:26 pmRNSTR-1: notification of major holdings
6th Feb 20243:39 pmRNSTR-1: Notification of Major Holdings
2nd Feb 20242:22 pmRNSTotal Voting Rights: Month End Disclosure
2nd Jan 202412:24 pmRNSTotal Voting Rights: Month End Disclosure
29th Dec 202310:55 amRNSTR-1: Notification of major holdings
20th Dec 20235:34 pmRNSDirector/PDMR Transaction
18th Dec 20237:00 amRNSTR-1: Notification of major holdings
5th Dec 202312:00 pmRNSInvestor Day
30th Nov 20236:04 pmRNSTotal Voting Rights: Month End Disclosure
10th Nov 20233:00 pmRNSDirector/PDMR Transaction
9th Nov 20239:30 amRNSDirector/PDMR Transaction
7th Nov 20233:00 pmRNSTotal Voting Rights: Month End Disclosure
7th Nov 202312:00 pmRNSStatement re Capital Markets Day
7th Nov 20237:00 amRNSIWG plc - Q3 2023 Trading Update
26th Oct 20233:28 pmRNSAGM UPDATE STATEMENT
20th Oct 20237:00 amRNSTR-1: Notification of Major Holdings - Correction
19th Oct 20234:10 pmRNSTR-1: Notification of Major Holdings
2nd Oct 20236:01 pmRNSTotal Voting Rights: Month End Disclosure
19th Sep 20231:25 pmRNSTR-1: Notification of major holdings
19th Sep 20237:31 amRNSTR-1: Notification of major holdings
4th Sep 20232:00 pmRNSTotal Voting Rights: Month End Disclosure
24th Aug 202312:00 pmRNSTR-1: Notification of major holdings
22nd Aug 202310:33 amRNSTR-1: Notification of Major Holdings
8th Aug 20237:00 amRNSH1 RESULTS ANNOUNCEMENT
3rd Aug 20239:53 amRNSTotal Voting Rights: Month End Disclosure
28th Jul 202312:26 pmRNSTR-1: Notification of Major Holdings
4th Jul 20231:06 pmRNSStandard form for notification of major holdings
3rd Jul 20237:00 amRNSTotal Voting Rights: Month End Disclosure
30th Jun 20239:11 amRNSDirector/PDMR Transaction
30th Jun 20239:10 amRNSTransaction Notification
29th Jun 20237:00 amRNSH1 2023 Pre-Close and Financing Update
5th Jun 20239:50 amRNSTotal Voting Rights: Month End Disclosure
24th May 20234:54 pmRNSDirector/PDMR Transaction
22nd May 20233:14 pmRNSDirector/PDMR Transaction
9th May 20231:55 pmRNSRESULTS OF ANNUAL GENERAL MEETING
2nd May 20239:59 amRNSTotal Voting Rights: Month End Disclosure
25th Apr 20237:00 amRNSFIRST QUARTER TRADING STATEMENT
6th Apr 20235:00 pmRNSAnnual General Meeting 2023
3rd Apr 20234:57 pmRNSTotal Voting Rights: Month End Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.